Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-1998 | |
| Cash Flows From Operating Activities | |
| Accounts receivable | -2,242 |
| Other Working Capital | 168 |
| Other Operating Activity | 3,110 |
| Operating Cash Flow | $1,036 |
| Cash Flows From Investing Activities | |
| PPE Investments | -130 |
| Net Acquisitions | -36,672 |
| Investing Cash Flow | $-36,802 |
| Cash Flows From Financing Activities | |
| Debt Issued | 40,362 |
| Debt Repayment | -900 |
| Common Stock Issued | 638 |
| Other Financing Activity | -179 |
| Financing Cash Flow | $39,921 |
| Beginning Cash Position | -1,219 |
| End Cash Position | 2,936 |
| Net Cash Flow | $4,155 |
| Free Cash Flow | |
| Operating Cash Flow | 1,036 |
| Capital Expenditure | -186 |
| Free Cash Flow | 850 |